Celltrion Prepares Aflibercept For Phase III

Follows In Footsteps Of Denosumab, Omalizumab And Ustekinumab Biosimilars

 
• By David Wallace
  
Clinical_Trial_Puzzle
The Eylea rival is the latest Phase III trial to fall into place for Celltrion • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products